M. Yoshida

Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats.

N. Abe, N. Ashizawa, A. Matsuura, 1997, Japanese journal of pharmacology.

Benzothiazol-2-ylcarboxylic acids with diverse spacers: A novel class of potent, orally active aldose reductase inhibitors

N. Abe, N. Ashizawa, T. Aotsuka, 1997 .

In Vitro and In Vivo Antidermatophyte Activities of NND-502, a Novel Optically Active Imidazole Antimycotic Agent

H. Yamaguchi, Y. Niwano, H. Kodama, 1998, Antimicrobial Agents and Chemotherapy.

Amelioration of neurovascular deficits in diabetic rats by a novel aldose reductase inhibitor, GP-1447: minor contribution of nitric oxide.

N. Ashizawa, A. Matsuura, Y. Sugiyama, 1998, Diabetes research and clinical practice.